Galectin Therapeutics, Inc. (GALT)

3.925 +0.28 (+7.83%) USD  |  NASDAQ  |  Oct 09, 16:00
3.925 0.00 (0.00%) After-Hours: 20:00
More

Galectin Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 14, 2026 --
June 23, 2026 --
May 28, 2026 --
May 15, 2026 --
March 31, 2026 --
December 31, 2025 --
December 19, 2025 --
December 17, 2025 --
November 14, 2025 --
Date Value
August 14, 2025 --
June 17, 2025 --
April 02, 2025 --
March 31, 2025 --
December 27, 2024 --
November 15, 2024 --
August 16, 2024 --
April 01, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Mirum Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade